Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree.

Glucocorticoid-suppressible hyperaldosteronism is a dominantly inherited form of hypertension believed to be caused by the presence of a hybrid CYP11B1/CYP11B2 gene which has arisen from an unequal crossing over between the two CYP11B genes in a previous meiosis. We have studied a French pedigree with seven affected individuals in which two affected individuals also have adrenal tumors and two others have micronodular adrenal hyperplasia. One of the adrenal tumors and the surrounding adrenal tissue has been removed, giving a rare opportunity to study the regulation and action of the hybrid gene causing the disease. The hybrid CYP11B gene was demonstrated to be expressed at higher levels than either CYP11B1 or CYP11B2 in the cortex of the adrenal by RT-PCR and Northern blot analysis. In situ hybridization showed that both CYP11B1 and the hybrid gene were expressed in all three zones of the cortex. In cell culture experiments hybrid gene expression was stimulated by ACTH leading to increased production of aldosterone and the hybrid steroids characteristic of glucocorticoid-suppressible hyperaldosteronism. The genetic basis of the adrenal pathologies in this family is not known but may be related to the duplication causing the hyperaldosteronism.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  K. Curnow,et al.  Genetic recombination as a cause of inherited disorders of aldosterone and cortisol biosynthesis and a contributor to genetic variation in blood pressure , 1995, Steroids.

[3]  G. Defayes,et al.  Human cultured adrenal fasciculata-reticularis cells are targets for angiotensin-II: effects on cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17 alpha-hydroxylase, and 3 beta-hydroxysteroid-dehydrogenase messenger ribonucleic acid and proteins and on steroidogenic responsiveness t , 1994, The Journal of clinical endocrinology and metabolism.

[4]  D. Naville,et al.  Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II. , 1994, The Journal of clinical investigation.

[5]  M. Sibony,et al.  Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. , 1993, Hypertension.

[6]  P. White,et al.  Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Kawamoto,et al.  The chimeric gene linked to glucocorticoid-suppressible hyperaldosteronism encodes a fused P-450 protein possessing aldosterone synthase activity. , 1992, Biochemical and biophysical research communications.

[8]  I. Artemenko,et al.  Regulation of cholesterol movement to mitochondrial cytochrome P450scc in steroid hormone synthesis , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  C. Gomez-Sanchez,et al.  Biotin-hydrazide derivatives for the development of steroid enzyme-linked immunoassays , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  J. Connell,et al.  Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Lalouel,et al.  Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase , 1992, Nature genetics.

[12]  P. White,et al.  Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. Suzuki,et al.  Zone-specific expression of aldosterone synthase cytochrome P-450 and cytochrome P-45011 beta in rat adrenal cortex: histochemical basis for the functional zonation. , 1992, Endocrinology.

[14]  K. Morohashi,et al.  Functional expression of cDNAs for bovine 11β-hydroxylase-aldosterone synthases, P450(11β)-2 and -3 and their chimeras , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  T. Kawamoto,et al.  Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Lalouel,et al.  A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension , 1992, Nature.

[17]  M. Seldin,et al.  Different isozymes of mouse 11 beta-hydroxylase produce mineralocorticoids and glucocorticoids. , 1991, Molecular endocrinology.

[18]  M. Tusié-Luna,et al.  The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. , 1991, Molecular endocrinology.

[19]  R. Voutilainen,et al.  Interaction of phorbol ester and adrenocorticotropin in the regulation of steroidogenic P450 genes in human fetal and adult adrenal cell cultures. , 1991, Endocrinology.

[20]  T. Kawamoto,et al.  Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. , 1990, Biochemical and biophysical research communications.

[21]  M. New,et al.  Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism. , 1990, The Journal of clinical endocrinology and metabolism.

[22]  P. White,et al.  Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). , 1989, The Journal of biological chemistry.

[23]  T. Ogishima,et al.  Isolation of two distinct cytochromes P-45011 beta with aldosterone synthase activity from bovine adrenocortical mitochondria. , 1989, Journal of biochemistry.

[24]  M. Okamoto,et al.  Aldosterone biosynthesis in mitochondria of isolated zones of adrenal cortex. , 1988, Journal of steroid biochemistry.

[25]  T. Yanase,et al.  A case of glucocorticoid-suppressible hyperaldosteronism with aldosterone producing adenoma. , 1988, Endocrinologia japonica.

[26]  C. Gomez-Sanchez,et al.  The production of monoclonal antibodies against aldosterone , 1987, Steroids.

[27]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[28]  K. Yanagibashi,et al.  The synthesis of aldosterone by the adrenal cortex. Two zones (fasciculata and glomerulosa) possess one enzyme for 11 beta-, 18-hydroxylation, and aldehyde synthesis. , 1986, The Journal of biological chemistry.

[29]  Y. Ueki,et al.  GLUCOCORTICOID‐SUPPRESSIBLE HYPERALDOSTERONISM Ultrastructural Observation of a Case , 1985, Acta pathologica japonica.

[30]  C. Gomez-Sanchez,et al.  Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism. , 1984, The Journal of clinical endocrinology and metabolism.

[31]  M. Land,et al.  Biosynthesis of 18-oxocortisol by aldosterone-producing adrenal tissue. , 1983, The Journal of biological chemistry.

[32]  M. New,et al.  Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism. , 1981, The Journal of clinical endocrinology and metabolism.

[33]  K. Yoshinaga,et al.  A case of glucocorticoid-responsive hyperaldosteronism. , 1968, The Journal of clinical endocrinology and metabolism.

[34]  R. E. Peterson,et al.  A New Form of Congenital Adrenal Hyperplasia1 , 1967 .

[35]  D. Sutherland,et al.  Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. , 1966, Canadian Medical Association journal.

[36]  H. Sambrook.  Molecular cloning : a laboratory manual. Cold Spring Harbor, NY , 1989 .

[37]  S. Quinn,et al.  Regulation of aldosterone secretion. , 1988, Annual review of physiology.

[38]  M. Waterman,et al.  Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. , 1988, Annual review of physiology.

[39]  R. E. Peterson,et al.  A new form of congenital adrenal hyperplasia. , 1967, The Journal of clinical endocrinology and metabolism.